Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT02072720
Eligibility Criteria:
Inclusion Criteria:
* patients that will receive chemoradiation following CROSS-schedule before surgery for esophageal carcinoma
* ability to give informed consent
* age 18 years or older
Exclusion Criteria:
* pregnancy
* evidence of bleeding diathesis, coagulopathy
* inflammation of the GI-tract
* brain metastases
* diastolic/ systolic hypertension, not responding to treatment
* arterial thromboembolism in medical history
* surgery within the month prior to start of bevacizumab treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02072720
Study Brief:
Protocol Section:
NCT02072720